Safety and Tolerability of Combining CGRP Monoclonal Antibodies with Gepants in Patients with Migraine: A Retrospective Study.
Taoufik AlsaadiReem SulimanVanessa SantosIbrahim Al QaisiPrincess CarminaBatool AldaherShadi HaddadYazan BaderPublished in: Neurology and therapy (2024)
The findings of this study demonstrate that combining CGRP mAbs with gepants is a safe and well-tolerated treatment approach for migraine. Future studies are warranted to further validate these findings and explore long-term outcomes.